451 related articles for article (PubMed ID: 20973112)
1. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
von Zur Muhlen C; von Elverfeldt D; Bassler N; Neudorfer I; Steitz B; Petri-Fink A; Hofmann H; Bode C; Peter K
Atherosclerosis; 2007 Jul; 193(1):102-11. PubMed ID: 16997307
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma.
Litovsky S; Madjid M; Zarrabi A; Casscells SW; Willerson JT; Naghavi M
Circulation; 2003 Mar; 107(11):1545-9. PubMed ID: 12654614
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
9. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
Chan JM; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Gibbs RG
Eur J Vasc Endovasc Surg; 2014 May; 47(5):462-9. PubMed ID: 24594295
[TBL] [Abstract][Full Text] [Related]
10. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.
Puppi J; Mitry RR; Modo M; Dhawan A; Raja K; Hughes RD
Cell Transplant; 2011; 20(6):963-75. PubMed ID: 21092412
[TBL] [Abstract][Full Text] [Related]
11. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
[TBL] [Abstract][Full Text] [Related]
12. OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice.
Wen 文颂 S; Liu 柳东芳 DF; Liu 刘振 Z; Harris S; Yao 姚玉宇 YY; Ding 丁琪 Q; Nie 聂芳 F; Lu 卢瞳 T; Chen 陈华俊 HJ; An 安艳丽 YL; Zang 臧凤超 FC; Teng 滕皋军 GJ
J Lipid Res; 2012 May; 53(5):829-838. PubMed ID: 22393161
[TBL] [Abstract][Full Text] [Related]
13. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.
Tu C; Ng TS; Sohi HK; Palko HA; House A; Jacobs RE; Louie AY
Biomaterials; 2011 Oct; 32(29):7209-16. PubMed ID: 21742374
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation.
Liu G; Hu Y; Xiao J; Li X; Li Y; Tan H; Zhao Y; Cheng D; Shi H
Sci Rep; 2016 Feb; 6():20900. PubMed ID: 26877097
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
[TBL] [Abstract][Full Text] [Related]
16. An experimental study on MR imaging of atherosclerotic plaque with SPIO marked endothelial cells in a rabbit model.
Zhou Q; Yang KR; Gao P; Chen WL; Yang DY; Liang MJ; Zhu L
J Magn Reson Imaging; 2011 Dec; 34(6):1325-32. PubMed ID: 21953575
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
Scharlach C; Kratz H; Wiekhorst F; Warmuth C; Schnorr J; Genter G; Ebert M; Mueller S; Schellenberger E
Nanomedicine; 2015 Jul; 11(5):1085-95. PubMed ID: 25659644
[TBL] [Abstract][Full Text] [Related]
18. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
Sterenczak KA; Meier M; Glage S; Meyer M; Willenbrock S; Wefstaedt P; Dorsch M; Bullerdiek J; Murua Escobar H; Hedrich H; Nolte I
BMC Cancer; 2012 Jul; 12():284. PubMed ID: 22784304
[TBL] [Abstract][Full Text] [Related]
20. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]